Opinion
As MAPS and Vine Ventures pioneer a $70 million social impact funding vehicle for MDMA-assisted psychotherapy, it’s unclear how it will be received by funders accustomed to traditional venture capital investment models.
Floris Wolswijk, the founder of Blossom, breaks apart a recent study about the mental health benefits of microdosing in this monthly column.
We all should ask what we can do to help ensure that psychedelic therapy is safe and ethical and how we should respond when accusations of abuse are brought to light.
As we face an increasingly destabilized world, can we fuse scientific understanding with indigenous people’s deep instinct of reciprocity?
Speaking to a mainstream American audience about psychedelic therapy revealed their central concerns, along with an eagerness to learn more.
With true psychedelics, the one essential bedrock factor is that they can and often do generate a mystical experience that is life changing.
Psychedelic risk reduction strategies will be especially important as we address the collective trauma of the pandemic.
With strong support in Congress, the passage of the MORE Act would expand treatment and economic opportunities while protecting cannabis users from losing public benefits and risking deportation.
As all unregulated market substances are prone to misrepresentation and adulteration, it’s important that those who consume substances learn how to check their drugs.
From landmark decriminalization measures to pathbreaking scientific research to the explosion of digital psychedelic culture, Lucid News shares 12 of the past year’s most impactful developments in psychedelics.
